AEM vs EXK

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

Endeavour Silver Corp. presents a stark contrast between explosive top-line growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 2/9. While revenue growth is exceptional at 309.20% YoY and analysts maintain a 'strong_buy' rating with a target of $16.17, the company suffers from negative profit margins (-25.48%) and a consistent failure to meet earnings estimates (0/4 beats in the last year). The stock is currently trading at a high Price/Book multiple (4.92), suggesting a premium valuation that is not yet supported by bottom-line stability. The overall outlook is neutral as the bullish commodity-driven analyst sentiment clashes with severe deterministic health warnings.